Medication Interaction Assessment for Polypharmacy Regimens

Introduction to Medication Interactions

The American Heart Association recommends monitoring for additive anticholinergic effects from the combination of anticholinergic medications and other drugs, such as loratadine, in patients taking multiple medications 1, 2

The American College of Cardiology recommends monitoring for muscle pain or weakness as a class effect of all statins, though the risk is not elevated by this specific combination of medications 2

The American Gastroenterological Association suggests that bile acid sequestrant therapy can reduce furosemide absorption and should be separated by at least 4-6 hours if prescribed, as patients on statins may eventually require additional lipid-lowering therapy 1
The American Heart Association notes that furosemide requires attention if bile acid sequestrants are ever added to therapy, but has no significant interactions with the current regimen 1

The American College of Cardiology recommends checking baseline and periodic liver transaminases (ALT, AST) for rosuvastatin, particularly if symptoms of hepatotoxicity develop 3
The American Heart Association suggests assessing for muscle symptoms (pain, weakness, cramping) at each visit as a statin class effect 2
The American College of Cardiology recommends monitoring INR more closely if warfarin is ever added to this regimen, as rosuvastatin can modestly affect warfarin metabolism 2

The American Heart Association advises against confusing rosuvastatin's interaction profile with simvastatin or lovastatin, which have extensive CYP3A4 metabolism and require dose limitations with many common cardiovascular drugs 2